News und Analysen
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever
Few things are more satisfying than watching a steadily growing stream of passive income flow into your brokerage account. If you've been holding back from investing because you think you can't
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever
Few things are more satisfying than watching a steadily growing stream of passive income flow into your brokerage account. If you've been holding back from investing because you think you can't
Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?
Cathie Wood and high dividend yields go together like... well, it's hard to finish that sentence because they don't go together at all. Wood and her Ark Invest funds are known for investing in
Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?
Cathie Wood and high dividend yields go together like... well, it's hard to finish that sentence because they don't go together at all. Wood and her Ark Invest funds are known for investing in
Is Viking Therapeutics Stock a Millionaire Maker?
There's no shortage of hype and excitement surrounding Viking Therapeutics (NASDAQ: VKTX) stock these days. The company has a promising weight loss drug candidate in its pipeline at a time when many
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
Price matters. That's true whether we're talking about cars, houses, laptops, or anything else -- including stocks.
Three Motley Fool contributors had price in mind when choosing Axsome Therapeutics
Where Will Viking Therapeutics Stock Be in 10 Years?
Viking Therapeutics (NASDAQ: VKTX) now ranks among the hottest biotech stocks on the market. The company's announcement in February of positive results from its phase 2 study of experimental weight
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
Does a rising tide really lift all boats? We could soon find out if the adage applies to the stock market.
A bull market is now well underway. The S&P 500 has soared more than 30% over the last 12
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
Does a rising tide really lift all boats? We could soon find out if the adage applies to the stock market.
A bull market is now well underway. The S&P 500 has soared more than 30% over the last 12
2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips?
Investors looking for stocks that can deliver heaps of passive income might want to turn their heads toward the healthcare sector. Right now, there are a couple of beaten-down stocks offering
2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips?
Investors looking for stocks that can deliver heaps of passive income might want to turn their heads toward the healthcare sector. Right now, there are a couple of beaten-down stocks offering
Will Pfizer Be a Trillion-Dollar Stock by 2035?
Some investors look at Pfizer (NYSE: PFE) as a has-been. That's understandable in some ways. Sales for the company's once-formidable COVID-19 franchise have tanked. So have Pfizer's overall revenue
Will Pfizer Be a Trillion-Dollar Stock by 2035?
Some investors look at Pfizer (NYSE: PFE) as a has-been. That's understandable in some ways. Sales for the company's once-formidable COVID-19 franchise have tanked. So have Pfizer's overall revenue
Could Viking Therapeutics Become the Next Eli Lilly?
Eli Lilly (NYSE: LLY) has become a giant in what may be a $100 billion market a few years from now. I'm talking about the world of weight loss drugs.
Doctors have been prescribing Mounjaro and the
Want Decades of Passive Income? 2 Stocks to Buy Now.
Dividend-paying stocks have generally outperformed those that don't pay dividends over the long term. That's partly because maintaining a healthy dividend requires a solid underlying business. And
EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
Why Illumina Stock Zoomed Higher on Thursday
A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P
Why Illumina Stock Zoomed Higher on Thursday
A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P
Why Illumina Stock Zoomed Higher on Thursday
A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
Investors are enjoying the ongoing bull run. The S&P 500 and Nasdaq Composite recently hit all-time highs. Though that's pretty exciting, bull markets don't last forever. Equities that can perform
EQS-Adhoc: STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR
Viking Therapeutics Stock Has 55% Upside, According to 1 Wall Street Analyst
There are potential share price gains, and then there are potential share price gains. In the view of one analyst, Viking Therapeutics (NASDAQ: VKTX) currently stands in front of the latter variety.
Is Pfizer the Best Dividend Stock for You?
If a dividend stock is struggling and falling in value, that pushes its yield up. This happens because while you are getting the same dividend, it is now costing you less money to acquire it. As
Is Pfizer the Best Dividend Stock for You?
If a dividend stock is struggling and falling in value, that pushes its yield up. This happens because while you are getting the same dividend, it is now costing you less money to acquire it. As